Report cover image

Humira Biosimilar Market

Publisher Coherent Market Insights
Published Jun 27, 2023
Length 155 Pages
SKU # CMI18107569

Description

Humira Biosimilar Market, By Product Type (Biosimilar Humira (Adalimumab), Interchangeable Biosimilar Humira), By Indication (Rheumatoid Arthritis, Psoriasis, Crohn\'s Disease, Ulcerative Colitis, Ankylosing Spondylitis, Juvenile Idiopathic Arthritis, Other Autoimmune Conditions), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Patient Age (Adult Patients, Pediatric Patients), By Application (Rheumatology, Dermatology, Gastroenterology, Other Therapeutic Areas), By Administration (Subcutaneous (SC) Injection, Intravenous (IV) Infusion), By Dosage Strength (40 mg/0.8 mL, Other dosage strengths), By End-User (Hospitals, Specialty Clinics, Others), By Packaging Type (Pre-filled Syringes, Autoinjectors, Vials), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030


Humira, a biologic medication used to treat autoimmune conditions like psoriasis and rheumatoid arthritis, is the most popular biologic medication in the world. Following the expiration of patent protection for Humira in some regions, biosimilars—which are highly similar copies of biologic medications in terms of safety, efficacy, and quality—have hit the market. These biosimilars encourage competition and may result in price reductions. They help lower costs and improve patient access to essential pharmaceuticals by offering more economical treatment options.

Market Dynamics

Patent expiration, cost savings, increasing prevalence of autoimmune diseases, favorable regulatory environment are major factors expected to drive growth of the global cerebral angiography market during the forecast period.

For instance, the market for multiple Humira biosimilars has been approved and introduced in Europe, which has been in the forefront of the acceptance of biosimilars. Due to the region's existing legal framework and policies supporting biosimilar adoption, there will likely be more market competition and potential cost reductions.

However, complex regulatory processes, intellectual property and patent litigation, and physician and patient awareness are expected to hamper growth of the global cerebral angiography market over the forecast period.

Key features of the study:
  • This report provides in-depth analysis of the global humira biosimilar market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global humira biosimilar market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Amgen Inc., Samsung Bioepis Co., Ltd., Sandoz International GmbH (Novartis AG), Mylan N.V., Boehringer Ingelheim International GmbH, Pfizer Inc., Fresenius Kabi AG, Coherus BioSciences, Inc., Biogen Inc., AbbVie Inc., Celltrion Inc., Amneal Pharmaceuticals, Inc., Lupin Pharmaceuticals, Inc., Merck & Co., Inc., Viatris Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global humira biosimilar market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global humira biosimilar market
Detailed Segmentation:
  • Global Humira Biosimilar Market, By Product Type:
  • Biosimilar Humira (Adalimumab)
  • Interchangeable Biosimilar Humira
  • Global Humira Biosimilar Market, By Indication:
  • Rheumatoid Arthritis
  • Psoriasis
  • Crohn's Disease
  • Ulcerative Colitis
  • Ankylosing Spondylitis
  • Juvenile Idiopathic Arthritis
  • Other Autoimmune Conditions
  • Global Humira Biosimilar Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Humira Biosimilar Market, By Patient Age:
  • Adult Patients
  • Pediatric Patients
  • Global Humira Biosimilar Market, By Application:
  • Rheumatology
  • Dermatology
  • Gastroenterology
  • Other Therapeutic Areas
  • Global Humira Biosimilar Market, By Administration:
  • Subcutaneous (SC) Injection
  • Intravenous (IV) Infusion
  • Global Humira Biosimilar Market, By Dosage Strength:
  • 40 mg/0.8 mL
  • Other dosage strengths
  • Global Humira Biosimilar Market, By End User:
  • Hospitals
  • Specialty Clinics
  • Others
  • Global Humira Biosimilar Market, By Packaging Type:
  • Pre-filled Syringes
  • Autoinjectors
  • Vials
  • Global Humira Biosimilar Market, By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
  • Company Profiles
  • Amgen Inc.
  • Samsung Bioepis Co., Ltd.
  • Sandoz International GmbH (Novartis AG)
  • Mylan N.V.
  • Boehringer Ingelheim International GmbH
  • Pfizer Inc.
  • Fresenius Kabi AG
  • Coherus BioSciences, Inc.
  • Biogen Inc.
  • AbbVie Inc.
  • Celltrion Inc.
  • Amneal Pharmaceuticals, Inc.
  • Lupin Pharmaceuticals, Inc.
  • Merck & Co., Inc.
  • Viatris Inc.

Table of Contents

155 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Product Type
Market Snapshot, By Indication
Market Snapshot, By Distribution Channel
Market Snapshot, By Patient Age
Market Snapshot, By Application
Market Snapshot, By Administration
Market Snapshot, By Dosage Strength
Market Snapshot, By End User
Market Snapshot, By Packaging Type
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Increasing prevalence of autoimmune diseases
Complex Regulatory Processes
Enhanced treatment choices and global market expansion
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Global Humira Biosimilar Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Global Humira Biosimilar Market , By Product Type, 2023-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Biosimilar Humira (Adalimumab)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
Interchangeable Biosimilar Humira
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
6. Global Humira Biosimilar Market , By Indication, 2023-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Rheumatoid Arthritis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
Psoriasis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
Crohn’s disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
Ulcerative Colitis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
Ankylosing Spondylitis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
Juvenile Idiopathic Arthritis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
Other Autoimmune Conditions
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
7. Global Humira Biosimilar Market , By Distribution Channel, 2023-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
8. Global Humira Biosimilar Market , By Patient Age, 2023-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Adult Patients
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
Pediatric Patients
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
9. Global Humira Biosimilar Market , By Application, 2023-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Rheumatology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
Dermatology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
Gastroenterology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
Other Therapeutic Areas
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
10. Global Humira Biosimilar Market , By Administration, 2023-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Subcutaneous (SC) Injection
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
Intravenous (IV) Infusion
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
11. Global Humira Biosimilar Market , By Dosage Strength, 2023-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
40 mg/0.8 mL
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
Other dosage strengths
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
12. Global Humira Biosimilar Market , By End User, 2023-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
Specialty Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
13. Global Humira Biosimilar Market , By Packaging Type, 2023-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Pre-filled Syringes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
Autoinjectors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
Vials
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
14. Global Humira Biosimilar Market , By Region, 2023-2030, (US$ Mn)
Introduction
Market Share Analysis, By Country, 2023 and 2030 (%)
Y-o-Y Growth Analysis, For Country 2018 –2030
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2023-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2023-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2023-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Region, 2023-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Administration, 2023-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Strength, 2023-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2023-2030,(US$ Mn)
Europe
Asia Pacific
Latin America
Middle East & Africa
15. Competitive Landscape
Amgen Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Samsung Bioepis Co.
Sandoz International GmbH (Novartis AG)
Mylan N.V.
Boehringer Ingelheim International GmbH
Pfizer Inc.
Fresenius Kabi AG
Coherus BioSciences
Biogen Inc
AbbVie Inc
Celltrion Inc
Amneal Pharmaceuticals
Lupin Pharmaceuticals
Merck & Co
Viatris Inc.
Analyst Views
16. Section
Research Methodology
About us
*Browse 24 market data tables and 28 figures on “Global Humira Biosimilar Market” - Global forecast to 2030

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us